Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Net Margin (2018 - 2025)

Exagen (XGN) has disclosed Net Margin for 8 consecutive years, with 37.73% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 1028.0% year-over-year to 37.73%, compared with a TTM value of 32.32% through Dec 2025, down 517.0%, and an annual FY2025 reading of 29.97%, down 280.0% over the prior year.
  • Net Margin was 37.73% for Q4 2025 at Exagen, up from 41.1% in the prior quarter.
  • Across five years, Net Margin topped out at 19.69% in Q2 2024 and bottomed at 192.87% in Q2 2022.
  • Average Net Margin over 5 years is 55.68%, with a median of 40.73% recorded in 2023.
  • The sharpest move saw Net Margin plummeted -14269bps in 2022, then skyrocketed 15741bps in 2023.
  • Year by year, Net Margin stood at 55.58% in 2021, then crashed by -112bps to 117.76% in 2022, then surged by 66bps to 40.25% in 2023, then skyrocketed by 32bps to 27.46% in 2024, then tumbled by -37bps to 37.73% in 2025.
  • Business Quant data shows Net Margin for XGN at 37.73% in Q4 2025, 41.1% in Q3 2025, and 25.59% in Q2 2025.